Cargando…
Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy
In the last 2 decades, health care management has been challenged by more aggressive therapy, the increased number of specialty medications, and more stringent guidelines to monitor adverse events or health risk. To promote patient safety, various communication requirements are mandated to increase...
Autor principal: | Projects, AMCP Special |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437540/ https://www.ncbi.nlm.nih.gov/pubmed/22468736 http://dx.doi.org/10.18553/jmcp.2012.18.3.268 |
Ejemplares similares
-
The Xyrem(®) (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017
por: Strunc, Michael J., et al.
Publicado: (2021) -
Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver function
por: Blanchette, Christopher M, et al.
Publicado: (2015) -
Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention
por: Brandenburg, Nancy A., et al.
Publicado: (2017) -
Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products
por: Pergolizzi, Joseph V, et al.
Publicado: (2013) -
Exploring the impact of mifepristone’s risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics()
por: Razon, Na’amah, et al.
Publicado: (2022)